UM

Browse/Search Results:  1-4 of 4 Help

Selected(0)Clear Items/Page:    Sort:
Improved in situ characterization of protein complex dynamics at scale with thermal proximity co-aggregation Journal article
Sun, Siyuan, Zheng, Zhenxiang, Wang, Jun, Li, Fengming, He, An, Lai, Kunjia, Zhang, Shuang, Lu, Jia Hong, Tian, Ruijun, Tan, Chris Soon Heng. Improved in situ characterization of protein complex dynamics at scale with thermal proximity co-aggregation[J]. Nature Communications, 2023, 14, 7697.
Authors:  Sun, Siyuan;  Zheng, Zhenxiang;  Wang, Jun;  Li, Fengming;  He, An; et al.
Favorite | TC[WOS]:3 TC[Scopus]:3  IF:14.7/16.1 | Submit date:2024/01/02
Corynoxine B targets at HMGB1/2 to enhance autophagy for α-synuclein clearance in fly and rodent models of Parkinson's disease Journal article
Qi Zhu, Juxian Song, Jia-Yue Chen, Zhenwei Yuan, Liangfeng Liu, Li-Ming Xie, Qiwen Liao, Richard D. Ye, Xiu Chen, Yepiao Yan, Jieqiong Tan, Chris Soon Heng Tan, Min Li, Jia-Hong Lu. Corynoxine B targets at HMGB1/2 to enhance autophagy for α-synuclein clearance in fly and rodent models of Parkinson's disease[J]. Acta Pharmaceutica Sinica B, 2023, 13(6), 2701-2714.
Authors:  Qi Zhu;  Juxian Song;  Jia-Yue Chen;  Zhenwei Yuan;  Liangfeng Liu; et al.
Favorite | TC[WOS]:7 TC[Scopus]:7  IF:14.7/14.1 | Submit date:2023/07/20
Autophagy  Corynoxine b  Hmgb1  Hmgb2  Neurodegenerative Disease  Parkinson's Disease  Pi3kc3  Α-synuclein  
Targeting macrophage autophagy for inflammation resolution and tissue repair in inflammatory bowel disease Review article
2023
Authors:  Wang,Er Jin;  Wu,Ming Yue;  Ren,Zheng Yu;  Zheng,Ying;  Ye,Richard D.; et al.
Favorite | TC[WOS]:10 TC[Scopus]:10  IF:6.3/6.7 | Submit date:2023/08/03
Autophagy  Efferocytosis  Inflammation  Inflammatory Bowel Diseases  Macrophage  Tissue Repair  
Toosendanin, a late-stage autophagy inhibitor, sensitizes triple-negative breast cancer to irinotecan chemotherapy Journal article
Zhang, Shuang, Dong, Yu, Chen, Xiuping, Tan, Chris Soon Heng, Li, Min, Miao, Kai, Lu, Jia Hong. Toosendanin, a late-stage autophagy inhibitor, sensitizes triple-negative breast cancer to irinotecan chemotherapy[J]. Chinese Medicine, 2022, 17, 55.
Authors:  Zhang, Shuang;  Dong, Yu;  Chen, Xiuping;  Tan, Chris Soon Heng;  Li, Min; et al.
Favorite | TC[WOS]:11 TC[Scopus]:12  IF:5.3/5.5 | Submit date:2022/05/31
Apoptosis  Autophagy Inhibition  Irinotecan  Lysosome  Sn-38  Toosendanin  Triple-negative Breast Cancer